QDEL QUIDEL CORP /DE/

Nasdaq www.quidel.com


$ 27.28 $ 1.14 (4.36 %)    

Wednesday, 15-Oct-2025 18:49:57 EDT
QQQ $ 603.32 $ 4.22 (0.71 %)
DIA $ 463.35 $ 0.00 (0 %)
SPY $ 665.84 $ 2.94 (0.44 %)
TLT $ 90.78 $ -0.20 (-0.22 %)
GLD $ 387.96 $ 6.60 (1.73 %)
$ 27.31
$ 26.16
$ 27.28 x 14
$ 29.98 x 1
$ 26.04 - $ 27.33
$ 22.05 - $ 49.45
909,324
na
1.14B
$ 0.71
$ 1.14
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-04-2022 03-31-2022 10-Q
2 02-18-2022 12-31-2021 10-K
3 11-04-2021 09-30-2021 10-Q
4 08-05-2021 06-30-2021 10-Q
5 05-07-2021 03-31-2021 10-Q
6 02-19-2021 12-31-2020 10-K
7 10-30-2020 09-30-2020 10-Q
8 07-31-2020 06-30-2020 10-Q
9 05-07-2020 03-31-2020 10-Q
10 02-13-2020 12-31-2019 10-K
11 10-31-2019 09-30-2019 10-Q
12 08-09-2019 06-30-2019 10-Q
13 05-09-2019 03-31-2019 10-Q
14 02-15-2019 12-31-2018 10-K
15 11-07-2018 09-30-2018 10-Q
16 08-08-2018 06-30-2018 10-Q
17 05-09-2018 03-31-2018 10-Q
18 02-27-2018 12-31-2017 10-K
19 11-02-2017 09-30-2017 10-Q
20 07-27-2017 06-30-2017 10-Q
21 04-27-2017 03-31-2017 10-Q
22 02-16-2017 12-31-2016 10-K
23 10-28-2016 09-30-2016 10-Q
24 07-28-2016 06-30-2016 10-Q
25 04-29-2016 03-31-2016 10-Q
26 02-23-2016 12-31-2015 10-K
27 10-29-2015 09-30-2015 10-Q
28 07-23-2015 06-30-2015 10-Q
29 04-24-2015 03-31-2015 10-Q
30 02-24-2015 12-31-2014 10-K
31 10-24-2014 09-30-2014 10-Q
32 07-24-2014 06-30-2014 10-Q
33 04-25-2014 03-31-2014 10-Q
34 02-27-2014 12-31-2013 10-K
35 10-25-2013 09-30-2013 10-Q
36 07-31-2013 06-30-2013 10-Q
37 04-24-2013 03-31-2013 10-Q
38 02-22-2013 12-31-2012 10-K
39 10-29-2012 09-30-2012 10-Q
40 07-27-2012 06-30-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 citigroup-downgrades-quidelortho-to-neutral-lowers-price-target-to-33

Citigroup analyst Patrick Donnelly downgrades QuidelOrtho (NASDAQ:QDEL) from Buy to Neutral and lowers the price target from...

 quidelortho-expands-quickvue-portfolio-with-launch-of-influenza-plus-sars-test-delivering-results-in-as-fast-as-10-minutes

Key Features and Benefits:Triple Detection Capability: Differentiates influenza A/B and COVID-19 in one test.Fast Results: Clea...

 ubs-maintains-neutral-on-quidelortho-lowers-price-target-to-26

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $29 to $26.

 citigroup-maintains-buy-on-quidelortho-lowers-price-target-to-40

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Buy and lowers the price target from $50 to $40.

 quidelortho-affirms-fy2025-adj-eps-guidance-of-207-257-vs-240-est-affirms-fy2025-sales-guidance-of-2600b-2810b-vs-2714b-est

QuidelOrtho (NASDAQ:QDEL) affirms FY2025 Adj EPS guidance from $2.07-$2.57 to $2.07-$2.57 vs $2.40 analyst estimate. Affirms FY...

 quidelortho-q2-adj-eps-012-beats-001-estimate-sales-613900m-beat-609978m-estimate

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.01 by ...

 quidelortho-and-bhlmann-expand-access-to-fecal-biomarker-testing-with-integration-of-turbo-assays-on-vitros-platforms

Gastrointestinal biomarker tests enhance patient diagnosis of IBD and pancreatic insufficiency on leading clinical chemistry pl...

 ubs-maintains-neutral-on-quidelortho-lowers-price-target-to-29

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $45 to $29.

 jefferies-upgrades-quidelortho-to-buy-announces-44-price-target

Jefferies analyst Tycho Peterson upgrades QuidelOrtho (NASDAQ:QDEL) from Hold to Buy and announces $44 price target.

 quidelortho-affirms-fy2025-adj-eps-guidance-of-207-257-vs-325-est-affirms-fy2025-sales-guidance-of-260b-281b-vs-281b-est

QuidelOrtho (NASDAQ:QDEL) affirms FY2025 Adj EPS guidance from $2.07-$2.57 to $2.07-$2.57 vs $3.25 analyst estimate. Affirms FY...

 quidelortho-q1-adj-eps-074-beats-011-estimate-sales-69280m-beat-62232m-estimate

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.11 by ...

 jp-morgan-maintains-underweight-on-quidelortho-lowers-price-target-to-25

JP Morgan analyst Casey Woodring maintains QuidelOrtho (NASDAQ:QDEL) with a Underweight and lowers the price target from $38...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION